{
    "url_original": "https://www.wsj.com/articles/as-covid-19-pills-roll-out-worry-mounts-that-resistance-could-develop-11642847405?mod=business_lead_pos7",
    "url": "as-covid-19-pills-roll-out-worry-mounts-that-resistance-could-develop-11642847405",
    "title": "As Covid-19 Pills Roll Out, Worry Mounts That Resistance Could Develop",
    "sub_head": "Researchers watch for signs the virus is morphing to evade new drugs, and study combining antivirals to stay a step ahead",
    "category_1": "Health",
    "time": "2022-01-22 05:30:00",
    "body": "Researchers and U.S. health regulators worry Covid-19 will figure out a way to evade important new pills, prompting efforts to look for signs of such resistance and find combinations to thwart it.<br />The treatments—Paxlovid from  Pfizer Inc.  and molnupiravir from  Merck  & Co. and Ridgeback Biotherapeutics LP—are the first drugs authorized by federal health regulators that people early in the course of an infection can easily take at home to avoid severe disease."
}